Artificial Organs Биоинженерия

Galunisertib During Normothermic Machine Perfusion Attenuates Profibrotic Signaling in Discarded Human Donor Kidneys

C. C. Pamplona, C. Ballester Bergada, C. L. Jaynes, T. L. Hamelink, V. A. Lantinga, B. Ogurlu, P. Ottens, P. Olinga, K. van Hateren, D. Touw, J. L. Hillebrands, H. G. D. Leuvenink, C. Moers, L. L. van Leeuwen
Wiley · 2026-11-18 · DOI 10.1111/aor.70281

Аннотация

ABSTRACT Introduction Early‐onset fibrosis limits kidney transplant success, causing early allograft failure in up to 50% of deceased donor kidneys within 10 years or excluding many from transplantation. Normothermic machine perfusion (NMP) offers a platform for targeted drug delivery to isolated organs, minimizing systemic effects. This study evaluated whether galunisertib modulates fibrosis‐associated molecular signaling when administered to discarded human kidneys during ex vivo NMP, while assessing treatment safety and pharmacokinetics. Methods Twelve discarded human kidneys underwent 4 h of oxygenated hypothermic perfusion followed by 6 h of NMP with galunisertib or vehicle ( n = 6). Precision‐cut kidney slices (PCKS) were then cultured for 48 h with either continued or discontinued galunisertib exposure. Endpoints included fibrosis‐related mRNA expression and pharmacokinetics. Results Galunisertib was administered during NMP and steadily excreted in urine without adverse effects on organ function. Continued exposure in PCKS significantly attenuated fibrosis‐related mRNA expression, including SERPINE1 (24 h: p = 0.0057; 48 h: p = 0.0046). Discontinuation increased ACTA2 expression ( p = 0.0156), while continued treatment prevented this phenomenon ( p = 0.0014). Conclusion NMP enabled targeted delivery of galunisertib to discarded human kidneys without detectable adverse effects on ex vivo renal function. Prolonged galunisertib exposure was associated with modest attenuation of fibrosis‐associated molecular markers during subsequent tissue culture. These findings provide proof‐of‐concept for pharmacological modulation of profibrotic signaling during ex vivo kidney perfusion.

Читать у издателя →